Cited by 95Amyotrophic Lateral Sclerosis ResearchCurcumin's Biomedical ApplicationsMuscle Physiology and Disorders

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation

Chico, Lucia, Ienco, Elena Caldarazzo, Bisordi, Costanza, Lo Gerfo, Annalisa, Petrozzi, Lucia, Petrucci, Antonio, Mancuso, Michelangelo, Siciliano, Gabriele·2018·CNS & Neurological Disorders - Drug Targets

Abstract

Objective: To investigate the efficacy of curcumin oral supplementation (600 mg/day, Brainoil), a natural antioxidant compound, in Amyotrophic Lateral Sclerosis (ALS). Methods: Patients were randomized into two groups: Group A received placebo for 3 months, then Brainoil for the following 3 months, Group B took Brainoil for 6 months. The evaluations were conducted at basal (T0), after 3 months of double blinded Brainoil or placebo treatment (T1), and after the 3 month open-label phase (T2). Clinical evaluations and oxidative stress biomarkers, including oxidative protein products (AOPPs), ferric reducing ability (FRAP), total thiols (T-SH) and lactate, were evaluated, compared to a control group, during an incremental forearm exercise test. Results: Over the entire study Group B showed a stable score of the ALS-FRS-r which decreased in Group A (p<0.01), in parallel with a reduction of AOPPs (p<0.01) which was not detected into Group A. Also FRAP exercise values remained stable in Group B, while in Group A they were reduced without treatment at T1 (0.05<p<0.01), for then increase at T2 with introduction of therapy (p<0.05). In Group B T1>T0 exercise lactate was lower compared to Group A (p<0.01). Compared to controls, the whole ALS population showed a greater oxidative stress (p<0.001), those treated with curcumin (Group B) exhibiting decreased exercise AOPPs at T2 with values approaching those of controls. Conclusion: Although further studies are needed to confirm these data, treatment with curcumin shows encouraging results indicating a slight slowdown in disease progression, improving aerobic metabolism and oxidative damage, this also contributing to deepen knowledge into the pathogenic mechanisms of ALS.

Overview

Integrity signals

Registry

Crossref · 10.2174/1871527317666180720162029

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Chico, L., Ienco, E. C., Bisordi, C., Lo Gerfo, A., Petrozzi, L., Petrucci, A., Mancuso, M., & Siciliano, G.
Affiliations
  • University of Pisa (IT)
  • Department of Clinical and Experimental Medicine, Neurological Clinic, University of Pisa, Pisa, Italy
  • Azienda Ospedaliera San Camillo-Forlanini (IT)
Corresponding author
Chico, Lucia
Venue
CNS & Neurological Disorders - Drug Targets
Published
2018-11-23
Volume
17
Issue
10
Pages
767-779
ISSN
  • 1568-007X (ISSN-L)
  • 1871-5273
OpenAlex
W2884528651
Cited by
95
References
34
Citations by year
2026: 8 · 2025: 7 · 2024: 12 · 2023: 22 · 2022: 17 · 2021: 14 · 2020: 10 · 2019: 4
FWCI
4.75
Type
journal article
Language
en
Open access
closed
Locations
  • CNS & Neurological Disorders - Drug Targets (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
amyotrophic lateral sclerosis, curcumin, oxidative stress, antioxidant supplementation, ferric reducing ability, total thiol, aerobic metabolism, disease progression, ALSFRS-R
MeSH terms
Superoxide Dismutase-1, Aged, Amyotrophic Lateral Sclerosis, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Curcumin, Double-Blind Method, Exercise Test, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Severity of Illness Index, Sulfhydryl Compounds, Time Factors, Body Mass Index, Treatment Outcome, Oxidative Stress, Hand Strength, Lactic Acid, Dietary Supplements, Advanced Oxidation Protein Products

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review